SCHEMBL23930792

SCHEMBL23930792

CCOC(=O)Cc1cc(C(=O)O)[nH]n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALPL P05186 4/20 0.46
LMNA P02545 1/20 0.45
HCAR3 P49019 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
KDM4E B2RXH2 4/20 0.43
ALDH1A1 P00352 3/20 0.43
CA9 Q16790 3/20 0.43
CA12 O43570 2/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
HPGDS O60760 1/20 0.41
RAB9A P51151 1/20 0.40
HPGD P15428 1/20 0.40
CYP1A2 P05177 1/20 0.39
POLB P06746 1/20 0.39
THRB P10828 1/20 0.39
CYP2C9 P11712 1/20 0.39
ALOX15 P16050 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20455653 0.84 HCAR3 (0.45) ALPLHCAR3SMN1; SMN2KDM4EALDH1A1
SCHEMBL8720083 0.82 SMN1; SMN2 (0.51) LMNASMN1; SMN2KDM4EALDH1A1CA9
SCHEMBL7860349 0.81 SMN1; SMN2 (0.46) LMNASMN1; SMN2KDM4EALDH1A1CA9
SCHEMBL28575636 0.79 SMN1; SMN2 (0.45) LMNASMN1; SMN2KDM4EALDH1A1CA9
SCHEMBL1431995 0.78 ALPL (0.54) ALPLHCAR3CA9CA12ALOX15
SCHEMBL5327425 0.77 LMNA (0.56) LMNASMN1; SMN2KDM4EALDH1A1MEN1
SCHEMBL5599241 0.75 HCAR3 (0.47) ALPLHCAR3CA9CA12
SCHEMBL1092 0.75 HCAR3 (0.54) ALPLHCAR3KDM4ECA9CA12
SCHEMBL31136151 0.74 MAPK1 (0.53) ALPLHCAR3CA9CA12KMT2A
SCHEMBL5599286 0.74 HCAR3 (0.46) ALPLHCAR3CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021215545-A1 ANTICANCER COMBINATION THERAPY WITH N-(1-ACRYLOYL-AZETIDIN-3-YL)-2-((1H-INDAZOL-3-YL)AMINO)METHYL)-1H-IMIDAZOLE-5-CARBOXAMIDE INHIBITOR OF KRAS-G12C TAIHO PHARMACEUTICAL CO., LTD. (JP) 2021-10-28 WO disclosed